Common Knee Injuries Such as ACL and Meniscus Tears Should be Repaired at Any Age

FREMONT, Calif. – Aug. 28, 2018- With football season underway, knee injuries such as ACL and meniscal tears may occur more frequently. While ACL reconstruction has become routine, a common but lesser-known injury is a torn meniscus. A meniscus is a cartilage “pad” in between the femur and tibia bone, that serves as the knee’s […]

Read More


Ceterix® Orthopaedics Announces FDA Clearance of New Suture Cartridge, Providing Increased Flexibility and Enhanced Options for Surgeons

New Size 0 Cartridge Offers Strength and Flexibility to Aid in Meniscal Repair FREMONT, Calif. – Aug. 27, 2018 – Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an added feature to the NovoStitch® Pro Meniscal Repair System […]

Read More


Orthopaedic Surgeon Uses Advanced Technique to Repair Twenty-year-old Knee Injury with the NovoStitch® Pro Meniscal Repair System

FREMONT, Calif. – Aug. 23, 2018 – Twenty years ago, athlete and law enforcement officer Charles Proscio injured his knee while practicing martial arts. Though he experienced knee pain for years, two decades later his symptoms became more troublesome and Charles sought care from orthopaedic surgeon Jaspreet Sekhon, M.D., for meniscus repair surgery hoping for […]

Read More


Ceterix® Orthopaedics Awarded New Patent for Circumferential Suturing Method in Meniscus Repair

New Patent Further Protects the Unique Circumferential Compression Stitch Method and Expands the Company’s Intellectual Property Portfolio for Orthopaedic Applications FREMONT, Calif. – June 26, 2018 – Ceterix Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced the issuance of U.S. Patent No. 10,004,492 related to the company’s method […]

Read More


Healthegy Podcast – MedTech Talk: Ceterix CEO John McCutcheon is Writing a Different Ending with New Tech That Can Save the Meniscus

“I came to Ceterix with the belief that if we showed that we had clinical benefit, we would do something really special,” said John McCutcheon, Ceterix® Orthopaedics, president and CEO. Listen to CEO John McCutcheon discuss his path to Ceterix Orthopaedics, the obstacles the company has overcome and how they are expanding the meniscus repair […]

Read More


Ceterix® Orthopaedics Announces FDA Clearance of the NovoStitch® Pro Meniscal Repair System, Offering Enhanced Features to Improve the Surgical Experience

Meniscus surgery is one of the most common surgical procedures in the United States, with one million performed annually FREMONT, Calif. – April 13, 2018– Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s NovoStitch® Pro Meniscal […]

Read More


Ceterix Orthopaedics Receives New Patent for Transosteal Anchoring Methods for Meniscal Root Repair

Patent Expands Intellectual Property Portfolio for Orthopaedic Applications FREMONT, Calif. – Mar. 23, 2018 – Ceterix® Orthopaedics, today announced the issuance of US Patent No. 9,913,638 relating to the company’s proprietary approach to knee meniscus and ACL repair, adding to an already expansive portfolio of innovative orthopaedic applications and issued patents. Ceterix’s new patent further protects […]

Read More


With Over 300 Procedures Completed, Arkansas Orthopedic Doctor Uses Novo Stitch Plus System to Keep Patient Running Toward Marathon Dream in Tokyo

FREMONT, Calif. – Mar. 14, 2018 – Dr. Chris Dougherty has completed more than 300 meniscus repairs with the Novo Stitch Plus. For one patient with a torn meniscus, the repair with the Novo Stitch Plus system meant keeping his active lifestyle after his surgery. Traditionally, a severely torn meniscus meant removal, which increases the chance […]

Read More


Ceterix Orthopaedics Announces Two Key Executive Promotions

Michael Hendricksen to Chief Operating Officer & Mark Saxton to Vice President of Sales and Marketing FREMONT, Calif. – Feb. 28, 2018 – Medical device company, Ceterix® Orthopaedics, Inc., developer of novel surgical tools for arthroscopic procedures, announces the promotions of Michael Hendricksen to Chief Operating Officer and Mark Saxton to Vice President, Sales and Marketing. Mr. Hendricksen, […]

Read More


Ceterix Announces Completion of Groundbreaking Study of Repair for Meniscal Tears Previously Thought Unrepairable

Clinical Trial Examined Suture Repair That Preserves Meniscal Tissue for Patients with Horizontal Meniscal Tears FREMONT, Calif. – Jan. 30, 2018 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally invasive orthopaedic procedures, today announced completion of enrollment in STITCH (A Prospective, Non-randomized, Multi-Center Investigation of All-suture-based […]

Read More



Use of Ceterix NovoStitch Plus System for Repair of Horizontal Meniscus Tears Supported by Three New Studies

Growing Recognition That Meniscus Can Be Preserved in Tears Previously Deemed Irreparable FREMONT, Calif. – Oct. 30, 2017 – Ceterix® Orthopaedics today announced the publication of three new studies in the journal Arthroscopy Techniques supporting the use of the company’s NovoStitch® Plus device for the repair of horizontal cleavage meniscal tears: • Horizontal Cleavage Meniscus Tear Treated […]

Read More


Ceterix Announces FDA Clearance and U.S. Commercial Availability of Next-Generation Meniscus Repair Device

NovoStitch Plus Enables Meniscus Preservation for More Patients MENLO PARK, Calif. – Sept. 22, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally invasive orthopaedic procedures, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. commercial availability of the company’s NovoStitch® Plus […]

Read More


Ceterix Announces Health Economics Data Demonstrating Cost Savings for Meniscus Repair

Data Presented at ISPOR Annual Meeting MENLO PARK, Calif. – May 19, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally invasive orthopaedic procedures, today announced the results of a health economics study related to meniscus surgery, the single most commonly-performed arthroscopic procedure in the […]

Read More


Ceterix Orthopaedics Announces $35 Million In New Funding

MENLO PARK, Calif. – May 7, 2015 – Ceterix® Orthopaedics today announced that it has entered into a term loan agreement with CRG and certain of its affiliate funds, providing Ceterix with up to $35 million of available borrowing capacity. “We are excited to have further support to continue our mission to save the meniscus […]

Read More


Ceterix Announces Publication of Studies Demonstrating Advantages of Meniscus Repair with Minimally Invasive Orthopaedic Suturing Device

Technology Offers Potential to Improve Repairs, Extend Repair to Additional Tear Types MENLO PARK, Calif. – March 06, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue procedures, today announced publication of positive findings from two biomechanical studies of the company’s proprietary NovoStitch® suture passer for meniscus repair […]

Read More


Ceterix Announces Addition of Three New Patents Protecting Technology for Minimally Invasive Orthopaedic Procedures

Intellectual Property Portfolio Totals More Than 180 Issued Claims MENLO PARK, Calif. – January 20, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive orthopaedic procedures, today announced the issuance of three new patents, adding to the company’s robust patent portfolio. The company’s innovative NovoStitch® suture passer is used in […]

Read More


Ceterix Announces Issuance of Key New Patent for Minimally Invasive Orthopaedic Procedures

Adds to Robust Intellectual Property Portfolio Totaling Over 160 Issued Claims MENLO PARK, Calif. – September 8, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve the ability to perform minimally invasive orthopaedic procedures, today announced the issuance of a new patent adding to the company’s existing patent portfolio. The company’s […]

Read More


New Literature Review Demonstrates Favorable Success Rates for Repairing Horizontal Meniscus Tears

Results Suggest Meniscus Repair May be Feasible for Many Patients MENLO PARK, Calif. – August 18, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced results of a systematic literature review evaluating the success rate of repairing horizontal meniscus tears, a common type of knee injury. Patients with […]

Read More


Ceterix Orthopaedics Completes $18 Million Financing

Company Announces Issuance of Two New U.S. Patents MENLO PARK, Calif. – May 13, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced that the company has closed $18 million in new financing. Previous investors Novo A/S, Versant Ventures and 5AM Ventures participated in the round, which also […]

Read More


Ceterix Announces Results from Biomechanical Studies of Minimally Invasive Orthopaedic Suturing Device

MENLO PARK, Calif. – May 1, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue procedures, today announced positive findings of recent biomechanical studies of the company’s proprietary NovoStitch™ technology. Adam Anz, M.D., of the Andrews Institute in Gulf Breeze, Fla., presented results of a study that evaluated […]

Read More


Ceterix Announces Issuance of Two Key Patents for Minimally Invasive Orthopaedic Suturing

MENLO PARK, California – August 6, 2013 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that expand and improve minimally invasive tissue procedures, today announced the issuance of two key patents for the company’s proprietary technology used in meniscal tear and other soft tissue injury procedures.1,2 Ceterix’s patents describe unique methods and designs […]

Read More


Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures

Featured in Peer-Reviewed Publication Describing Innovative Techniques for Knee Meniscus Repair MENLO PARK, California – July 16, 2013 – Ceterix® Orthopaedics, Inc. today announced commercial availability of the company’s NovoStitch™ suture passer in the United States. The company’s device enables surgeons to place stitches in tight joint compartments, including those in knees, hips and shoulders, […]

Read More


Ceterix Orthopaedics Completes $19.5 Million Series B Financing

MENLO PARK, California – January 22, 2013 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced that the company has completed a $19.5 million series B financing. The round was led by new investor Novo Ventures. Previous investors Versant Ventures and 5AM Ventures also participated in the round. In […]

Read More


Kevin Sidow Joins Ceterix Orthopaedics Board of Directors as Chairman

MENLO PARK, California – November 2011 – Medical device company, Ceterix® Orthopaedics, Inc., developer of novel surgical tools for arthroscopic procedures, today announced that Kevin Sidow has joined the company’s Board of Directors as Chairman. Mr. Sidow, President and CEO of Moximed, Inc., has over twenty years of orthopaedic medical device experience. Prior to his […]

Read More


SuturePro Technologies Becomes Ceterix Orthopaedics

MENLO PARK, California – April 2011 –SuturePro Technologies, Inc., a medical device company that develops novel surgical tools for arthroscopic procedures, today announced that it has changed its name to Ceterix Orthopaedics. “This new name allows for a broader representation of products the company plans to launch,” said John McCutcheon, Ceterix President and CEO. Ceterix […]

Read More


SuturePro Technologies Closes $8.1 Million Series A Financing

MENLO PARK, CALIFORNIA – October 2010 – Medical device company, SuturePro Technologies, Inc., developer of novel surgical tools for arthroscopic procedures, today announced that it closed an $8.1 million Series A funding. The effort was led by Versant Ventures and 5AM Ventures. “This round of funding is a critical step in further developing the inventions […]

Read More